January 16, 2020
1 min read
Save
COSMIC-HF
Issue: January 2020
Omecamtiv mecarbil (Amgen) vs. placebo to increase contractility in patients with HF.

Omecamtiv mecarbil (Amgen) vs. placebo to increase contractility in patients with HF.